which the macula densa (MD) senses increases or deBackground. Previous studies have suggested that nitric oxcreases in distal NaCl delivery and causes an increase ide (NO) produced within cells of the macula densa (MD) or decrease in afferent arteriole (Af-Art) resistance, remodulates tubuloglomerular feedback (TGF). We tested the spectively. Thus, TGF participates in the regulation of hypothesis that NO produced in the MD acts locally as an autacoid to activate soluble guanylate cyclase and cGMPglomerular filtration rate and distal NaCl delivery [1, 2] . Here we investigated the following hypotheses: (1) ylate cyclase inhibitor did not potentiate TGF, suggesting that the effect of NO occurred at the MD via a cGMP-dependent NO produced in the MD by nNOS inhibits TGF via mechanism. To determine whether the effect of NO in the MD activation of guanylate cyclase, which generates cGMP; was entirely mediated by cGMP, TGF was studied after giving this in turn activates a cGMP-dependent protein kinase.
(1) LY83583 or (2) LY83583 plus 7NI. Adding the nNOS inhibi-(2) Most, if not all, of the effect of NO at the MD is tor to the MD did not potentiate the TGF response further. mediated by a cGMP-dependent mechanism, rather than Conclusions. We concluded the following: (1) NO produced by the MD inhibits TGF via stimulation of soluble guanylate by other mediators; and (3) NO acts as an autacoid at cyclase, generating cGMP and activating cGMP-dependent the level of the MD itself, rather than by diffusing to protein kinase; (2) NO acts on the MD itself rather than by the Af-Art. To test these hypotheses, microdissected rabdiffusing to the Af-Art; and (3) most, if not all, of the effect bit Af-Arts with the MD attached were microperfused of NO in the MD is due to a cGMP-dependent mechanism rather than to other NO mediators.
in vitro. The TGF response was determined by measuring the Af-Art diameter before and after increasing NaCl in the MD perfusate. TGF was studied before (control potentiating effects of nNOS or guanylate cyclase inhibitors. To determine that drugs perfused into the tubular compartment did not act in the vascular compartment were 65.4 mmol/L Na and 50 mmol/L Cl. The MD was perfused at a rate of 10 nL/min. or vice versa, we studied (1) the Af-Art vasodilator response to acetylcholine (a NO-cGMP-dependent vasoBath volume was 1 mL. The bath consisted of MEM containing 0.15% BSA and was exchanged continuously dilator) when MD guanylate cyclase was inhibited and (2) whether adding a guanylate cyclase inhibitor to the at a rate of 1 mL/min. Microdissection and cannulation were completed within 90 minutes at 8ЊC, after which Af-Art perfusate would potentiate TGF. We found the following: (1) NO produced by the MD inhibits TGF the bath was gradually warmed to 37ЊC for the rest of the experiment. Once the temperature was stable, a 30-via stimulation of soluble guanylate cyclase, generating cGMP and activating cGMP-dependent protein kinase; minute equilibration period was allowed before taking any measurements. Images were displayed at magnifica-(2) NO acts on the MD itself rather than by diffusing to the Af-Art; (3) most, if not all, of the effect of NO in tions of up to ϫ1980 and recorded with a video system. Af-Art diameter was measured with a MetaMorph image the MD is due to a cGMP-dependent mechanism rather than to other NO mediators; and (4) was purchased from Sigma Chemical Co. Briefly, young male New Zealand white rabbits were given tap water ad libitum and fed standard rabbit chow; Statistics they were then anesthetized with ketamine [50 mg/kg, Each separate experiment was approached in an analintramuscularly (IM)], xylazine (50 mg/kg IM), and penogous manner. The designs were repeated measures with tobarbital (40 mg/kg IM) and were given an intravenous the same Af-Art being measured under different condiinjection of heparin (500 U). The kidneys were removed tions. In all cases, a subset of all possible contrasts was and sliced along the corticomedullary axis, and slices were specified in advance as being of primary importance. To placed in ice-cold minimum essential medium (MEM; analyze a specific difference, a paired t-test was used. Gibco, Grand Island, NY, USA) containing 5% bovine All tests were two-sided, and results are presented as serum albumin (BSA; Sigma, St. Louis, MO, USA). Usmean Ϯ SEM. For each experiment, comparisons of ining a stereomicroscope (Olympus SZH, Tokyo, Japan) terest were considered a set, and Holm's multiple comas described previously [4], a single superficial Af-Art parisons procedure was used to adjust for multiple testand its intact glomerulus from each rabbit were microdising. P Ͻ 0.05 was considered significant. sected together with adherent tubular segments consisting of portions of the thick ascending limb, MD, and RESULTS early distal tubule. The microdissected sample was transferred to a temperature-regulated chamber mounted on Because NO stimulates cGMP production in other nephron segments via soluble guanylate cyclase, we inan inverted microscope (Olympus IMT-2) with Hoffmann modulation. Both the Af-Art and the end of either vestigated the effect of adding an inhibitor of soluble guanylate cyclase to either the MD or Af-Art perfusate the distal tubule or thick ascending limb were cannulated with an array of glass pipettes as described previously [4] .
on TGF as a means of elucidating the mechanism and site of action of NO. First, we studied the effect of the solIntraluminal pressure of the Af-Art was measured by Landis's technique, using a fine pipette introduced into uble guanylate cyclase inhibitor LY83583 (10 Ϫ6 mol/L) on TGF when added to the MD perfusate. When the the lumen through the perfusion pipette. The Af-Art was perfused with oxygenated MEM (95% O 2 ; 5% CO 2 ) MD perfusate was changed from low to high NaCl during the control period, the Af-Art diameter decreased from containing 5% BSA, and intraluminal pressure was maintained at 60 mm Hg throughout the experiment.
18.5 Ϯ 1.3 to 15.4 Ϯ 1.3 m, a reduction of 3.2 Ϯ 0.5 m (N ϭ 6). When LY83583 was present in the MD The MD was perfused with a modified Krebs-Ringer bicarbonate buffer. The low-NaCl solution contained (in perfusate, changing NaCl from low to high caused the diameter of the Af-Art to decrease from 18.7 Ϯ 1.3 to mmol/L) 15 NaHCO 3 , 0.96 NaH 2 PO 4 , 0.24 Na 2 HPO 4 , 5 KHCO 3 , 1.2 MgSO 4 , 1.0 CaCl 2 , 5.5 glucose, and 1.0 Na 12.3 Ϯ 1.5 m, a reduction of 6.3 Ϯ 1.1 m (P Ͻ 0.031 compared with control TGF). Thus, TGF was signifiacetate; thus, the final Na and Cl concentrations were 17.4 mmol/L Na and 2 mmol/L Cl. The high-NaCl solucantly enhanced by inhibiting soluble guanylate cyclase in the MD (Fig. 1) . tion had a similar composition except that 48 mmol/L NaCl was added; thus, the final Na and Cl concentrations
In a separate series of experiments, we studied increased diameter from 10.1 Ϯ 1.4 to 17.8 Ϯ 1.2 m (P ϭ 0.006); this increase was similar to that observed in the absence of LY83583. These data indicate that inhibiting MD soluble guanylate cyclase does not affect NO-cGMP-induced dilation of the Af-Art. We also measured the change in diameter induced by high NaCl before and during perfusion of the Af-Art with LY83583. When the MD perfusate was changed from low to high NaCl during the control period, the Af-Art diameter decreased by 3.0 Ϯ 0.9 m (N ϭ 6; Fig.  3 ). After adding 10 Ϫ6 mol/L LY83583 to the lumen of the Af-Art, the diameter did not change significantly. When the MD perfusate was changed from low to high 0.3 m, N ϭ 3). These data indicate that inhibiting AfArt soluble guanylate cyclase does not affect TGF. When taken all together, the data also indicate that when a substance is perfused into the MD, it does not directly whether the guanylate cyclase inhibitor LY83583 peraffect the Af-Art and vice versa. fused into the MD inhibited the vasodilator effect of Because inhibition of soluble guanylate cyclase in the acetylcholine on preconstricted Af-Arts. When the MD MD augmented TGF, we next investigated whether inwas perfused with low-NaCl solution, adding 2 ϫ 10 Ϫ7 creasing cGMP in the MD with a permeable analogue of mol/L norepinephrine to the bath constricted Af-Arts cGMP blunts TGF when MD nNOS or soluble guanylate to 59% of basal diameter (Fig. 2) . Adding acetylcholine cyclase is inhibited. When the MD perfusate was changed (10 Ϫ6 mol/L) to the arteriolar perfusate increased diamefrom low to high NaCl, the Af-Art diameter decreased ter from 11.4 Ϯ 1.1 to 17.6 Ϯ 1.2 m (P ϭ 0.006). When from 20.3 Ϯ 1.0 to 17.3 Ϯ 1.2 m (N ϭ 7, P ϭ 0.006; it was removed, diameter returned to 10.1 Ϯ 1.2 m. Fig. 4A ). Adding 10 Ϫ5 mol/L 7-nitroindazole (7NI) to Adding LY83583 to the low-NaCl MD perfusate did not the high-NaCl solution (to inhibit nNOS) decreased the affect diameter. When acetylcholine was now added to the arteriolar perfusate in the presence of LY83583, it diameter further to 15.3 Ϯ 1.5 m (P ϭ 0.001). When cGMP was added to the MD perfusate, the Af-Art diamto high NaCl, the Af-Art diameter decreased from 18.4 Ϯ eter increased to 18.8 Ϯ 1.3 m (P Ͻ 0.004), thus re-1.1 to 15.8 Ϯ 1.1 m, a reduction of 2.6 Ϯ 0.3 m (N ϭ versing the effect of 7NI. Similar results were found 7). When the MD perfusate was changed from low to when MD soluble guanylate cyclase was inhibited. When high NaCl in the presence of KT5823, the Af-Art diamethe MD perfusate was changed from low to high NaCl, ter decreased from 17.9 Ϯ 1.0 to 13.6 Ϯ 1.5 m, a reducthe Af-Art diameter decreased from 18.2 Ϯ 1.0 to 15.0 Ϯ tion of 4.0 Ϯ 0.7 (P Ͻ 0.023 vs. control TGF; Fig. 6 ). 1.1 m (N ϭ 6, P Ͻ 0.001). Adding LY83583 (10 Ϫ6 mol/L) Thus, inhibiting cGMP-dependent kinase in the MD augfurther decreased the diameter from 15.0 Ϯ 1.1 to 12.0 Ϯ mented TGF. 1.3 m (P ϭ 0.001). When cGMP was added to the MD Because NO generated at the MD may blunt TGF perfusate, the Af-Art diameter increased to 16.7 Ϯ 1.6 m by activating other second-messenger cascades besides (P Ͻ 0.002), reversing the effect of LY83583 (Fig. 4B) .
those dependent on cGMP, we investigated the effect To rule out the possibility that changes in Af-Art diamof 7NI on TGF while inhibiting MD soluble guanylate eter reflect a direct effect of cGMP on the arteriole rather cyclase. When the MD perfusate was changed from low than the MD cells, we tested whether adding cGMP to to high NaCl in the presence of LY83583, Af-Art diameter the low-NaCl MD perfusate could dilate the arteriole.
decreased by 3.8 Ϯ 0.8 m (from 19.2 Ϯ 1.5 to 15.4 Ϯ When the MD was perfused with low-NaCl solution and 1.3 m, N ϭ 6). Adding 7NI to the MD perfusate in the 2 ϫ 10 Ϫ7 mol/L norepinephrine was added to the bath, presence of LY83583 did not constrict the Af-Art further the Af-Art was reduced to 52% of its original diameter (Fig. 7) . In the presence of both inhibitors, when the (P ϭ 0.005, N ϭ 5; Fig. 5 ). When cGMP was added MD perfusate was switched from low to high NaCl, the only to the lumen of the MD while perfusing it with diameter decreased by 4.2 Ϯ 1.6 m, not significantly low-NaCl solution, the Af-Art diameter remained undifferent from control (from 19.6 Ϯ 1.9 to 15.4 Ϯ 1.3 m). changed. Subsequently, when acetylcholine (10 Ϫ6 mol/L) Thus, the effect of inhibiting MD soluble guanylate cywas added to the lumen of the Af-Art, the diameter clase on TGF was not additive with inhibiting nNOS. increased from 8.26 Ϯ 1.0 to 15.3 Ϯ 1.9 m (P ϭ 0.005). The data shown in Figures 4 and 5 indicate that directly DISCUSSION augmenting MD cGMP can blunt TGF and that cGMP Several studies have shown that NO generated by the perfused into the MD does not diffuse to the Af-Art in MD blunts TGF [3] [4] [5] . NO produced by the MD could sufficient quantities to alter its diameter (Fig. 5) .
have several sites of action. First, it could act as an autacGMP may activate several enzymes, including cGMPcoid, affecting processes in the MD itself. Alternatively, dependent protein kinase. To test whether activation of it could act in the juxtaglomerular mesangial cells, which cGMP-dependent protein kinase is a necessary step in are most likely vital to transmission of the signal from the NO second-messenger cascade, we investigated the the MD to the Af-Art. Finally, NO may diffuse from the effect of the cGMP-dependent protein kinase inhibitor MD to the Af-Art and thus cause it to dilate. To clarify KT5823 (2 ϫ 10 Ϫ6 mol/L) on TGF. During the control period, when the MD perfusate was changed from low NO's site of action, we first needed to show where soluble within the MD rather than by diffusing to the mesangium or Af-Art. They also indicate that drugs perfused into the tubular compartment do not act in the vascular compartment and vice versa.
Given that vasoconstrictors such as angiotensin augment TGF and vasodilators such as atrial natriuretic cells by adding LY83583 to the arteriolar perfusate had no effect on TGF. These data suggest that NO produced by the endothelial cells of the Af-Art does not significantly alter TGF. guanylate cyclase is activated by NO produced in the Although it is well established that NO inhibits TGF, MD. Our data show that adding a soluble guanylate how it does so remains unclear. To address this question, cyclase inhibitor to the tubular perfusate to block it in we investigated the role of cGMP, NO's second messenthe MD augments TGF; thus, NO produced in the MD ger in many other tissues [7, 9, 11, 12] . Our data show blunts TGF by acting as an autacoid within this specialthat when soluble guanylate cyclase was blocked at the ized plaque of cells rather than by diffusing to the Af-MD, TGF was enhanced. Furthermore, when we inArt and promoting vasodilation. These results cannot be creased cGMP levels in the MD in the presence of 7NI explained by the inhibitor diffusing to the Af-Art or (to inhibit nNOS) or LY83583 (to inhibit guanylate cymesangial cells in sufficient quantities to alter NOclase), the Af-Art diameter increased. Finally, inhibiting induced vasodilation, because (1) directly blunting solucGMP-dependent protein kinase in the MD also enble guanylate cyclase in the Af-Art and mesangial cells by adding LY83583 to the arteriolar perfusate had no hanced TGF. From these findings, we concluded that NO stimulates soluble guanylate cyclase in the MD and effect on TGF, and (2) perfusing the MD with an inhibitor of soluble guanylate cyclase did not alter endotheincreases cGMP, which subsequently activates cGMPdependent protein kinase. Activation of cGMP-depenlium-dependent relaxation of the arteriole by acetylcholine. Furthermore, perfusing the MD with dibutyryl dent protein kinase consequently diminishes another process (as yet unknown) that is necessary for full exprescGMP to augment cGMP levels in this segment blunted TGF, but did not dilate Af-Arts preconstricted by norsion of TGF. Although our data indicate that NO primarily acts via epinephrine. Taken together, these data show that NO produced by the MD blunts TGF by acting as an autacoid cGMP and cGMP-dependent protein kinase, the experi- ments discussed previously in this article do not rule out caused a marked release of cGMP, which was reduced by the NOS inhibitor N G -nitro-l-arginine [9] . Inhibiting the possibility that another second-messenger cascade is activated. To test this possibility, we examined the effect NOS with N G -monomethyl-l-arginine has been shown to lead to a dose-dependent decrease in cGMP in renal of inhibiting MD nNOS on TGF after MD soluble guanylate cyclase had been inhibited, but found that this had interstitial fluid and urine [7] . In addition, NO alters nephron transport through a cGMP-linked mechanism. no effect on Af-Art diameter. These data suggest that the effect of NO on the MD is mediated mainly by Roczniak and Burns showed that sodium nitroprusside (SNP) inhibits Na transport via a cGMP-dependent cGMP.
Several other studies have shown that NO stimulates mechanism in the proximal tubule [10] . We have also shown that NO inhibits transport of water in the cortical soluble guanylate cyclase and augments cGMP generation in other tissues [7, 9, 13, 14] . Intravenous infusion collecting duct and Cl in the thick ascending limb by stimulating cGMP production [15, 16] . of NO donors significantly reduced mean arterial blood pressure and urinary output and increased tubular secreIncreased intracellular cGMP may activate cGMPdependent protein kinase or affect other cGMP-dependent tion of cGMP [13] . In the isolated perfused rat kidney, an injection of sodium nitroprusside or acetylcholine enzymes [11, 12, 17, 18] . cGMP-dependent protein kinase
